MetaVia Inc.
MTVA
Rankning i aktier
#32966
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a... Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associated steatohepatitis (MASH). This follows the successful completion of Phase 1 trials for type 2 diabetes mellitus (T2DM), and the compound holds promise for use as both a standalone therapy and in combination treatments. Another significant asset, DA-1726, an innovative oxyntomodulin analogue that functions as a dual agonist for GLP-1 and glucagon receptors, is presently in preclinical development specifically for treating obesity. MetaVia's broader therapeutic pipeline also includes ANA001, a distinct oral niclosamide formulation intended for moderate COVID-19 patients; NB-01, designed to address painful diabetic neuropathy; NB-02, targeting cognitive impairment; and Gemcabene, for the management of dyslipidemia. The company engages in strategic partnerships, notably a licensing agreement with Pfizer Inc. for the research, development, manufacturing, and commercialization of Gemcabene. Additionally, a joint research collaboration with Dong-A ST and ImmunoForge supports the advancement of DA-1726. The entity adopted its current name, MetaVia Inc., in November 2024, transitioning from its former identity as NeuroBo Pharmaceuticals, Inc.
Aktiekurs
$1.25
Marknadsvärde
$8.24M
Förändring (1 dag)
-0.79%
Förändring (1 år)
-23.31%
Land
US
Handel MetaVia Inc. (MTVA)
Kategori
Healthcare
Marknadsvärde för MetaVia Inc.(MTVA)
Marknadsvärde: $8.24M
Från och med October 2026 har MetaVia Inc. ett börsvärde på $8.24M. Detta gör MetaVia Inc. till det 32966th mest värdefulla företaget i världen enligt våra data. Börsvärdet, även kallat market cap, är det totala marknadsvärdet av ett börsnoterat företags utestående aktier och används ofta för att uppskatta ett företags värde.
Marknadsvärdehistorik för MetaVia Inc. från 2016 till 2026
MTVA jämfört med topp 5 mest populära stocks
